Cited 0 times in
Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.